Is Genentech's asking price of $112 reasonable?
Yes
44% (55 votes)
No
52% (66 votes)
Not sure
4% (5 votes)
Total votes: 126
THE LIBRARY: WEBINAR
Getting the most PoC data in Phase I cancer studies
The hunt for proof-of-concept data is steadily moving upstream in the clinic. Join FierceBiotech on June 12th as three clinical trial experts tackle the question of how you can best design a Phase I study to get a readout on efficacy. Topics will include: enrollment, dosing and the best possible use of biomarkers for experimental cancer drugs. Register Today!
EVENTS
- MDMA Annual Meeting May 30th - June 1st, 2012 — Washington, DC
- SFE & Commercial Excellence USAJune 12-14, 2012 — Woodbridge, NJ
- Clinical Trials Eastern Europe Webinar SeriesMay 15-June 12 — Eastern Europe
Press Releases
- BASi Reports Fiscal 2012 Second Quarter Results
- Quanticate expands operations in India
- Piramal Healthcare Limited to Acquire Decision Resources Group
- Dehaier Medical launches U.S. Subsidiary to fuel further global expansion
- Pfizer To Present New Data In Advanced Kidney, Lung And Hematologic Cancers At 2012 ASCO Annual Meeting
- More Press Releases
Latest Commentary